Drug Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

Drug Name INBRX-105
Trade Name
Synonyms INBRX105|INBRX 105|ES 101|ES-101|ES101
Drug Descriptions

INBRX-105 (ES 101) is a bispecific antibody that binds to TNFRSF9 (CD137) and PD-L1 (CD274), potentially resulting in enhanced anti-tumor immunity and tumor cell lysis (NCI Drug Dictionary).

DrugClasses Immune Checkpoint Inhibitor 148 PD-L1/PD-1 antibody 117 TNFRSF9 Antibody 30
CAS Registry Number NA
NCIT ID C159978


  • Case insensitive filtering will display rows if any text in any cell matches the filter term
  • Use simple literal full or partial string matches
  • Separate multiple filter terms with a space. Any order may be used (i. e. a b c and c b a are equivalent )
  • Filtering will only apply to rows that are already loaded on the page. Filtering has no impact on query parameters.
  • Use quotes to match on a longer phrase with spaces (i.e. "mtor c1483f")


  • Generally, the default sort order for tables is set to be first column ascending; however, specific tables may set a different default sort order.
  • Click on any column header arrows to sort by that column
  • Hold down the Shift key and click multiple columns to sort by more than one column. Be sure to set ascending or descending order for a given column before moving on to the next column.

Therapy Name Drugs Efficacy Evidence Clinical Trials
INBRX-105 INBRX-105 0 1
INBRX-105 + Pembrolizumab INBRX-105 Pembrolizumab 0 1

Additional content available in CKB BOOST